Use of darunavir in HIV-1-infected individuals in routine clinical practice from 2012 to 2016 in France

ConclusionsDarunavir-containing regimens yielded similarly high rates of viral suppression in PLHIV whether they were ARV naive or ARV experienced switching to darunavir while failing therapy, or of maintaining VS in ARV-experienced PLHIV switching to darunavir while virologically controlled.
Source: Journal of Antimicrobial Chemotherapy - Category: Microbiology Source Type: research